mRNA vaccines

Moderna, Pfizer, COVID-19 Vaccine, mRNA vaccines, Alnylam Pharmaceuticals, CureVac, BioNTech, Patent infringement

Legal Engagements Amid Scientific Advancements: Alnylam’s Ongoing Interplay with Moderna

Anika Sharma

In the intricate choreography of the biopharmaceutical world, where innovation and intellectual property intertwine, a dramatic legal ballet unfolds. Alnylam, ...